Therapeutics In Ovo
|
Oregon Health & Science University / Charles Keller |
Innovation Grants |
2008 |
Oregon |
Therapies for SHH-subtype Medulloblastoma |
Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |
TLE1 Tumor Suppressor as a Key Regulator of myc Induced Leukemia |
Massachusetts General Hospital / Selvi Ramasamy |
Young Investigator Grants |
2010 |
Massachusetts |
To test the feasibility, acceptability and effectiveness of a sleep hygiene and relaxation intervention to improve sleep and fatigue for children receiving maintenance therapy for acute lymphoblastic leukemia |
Hospital for Sick Children / Sue Zupanec |
Nurse Researcher Grants |
2010 |
Ontario |
Towards LNP Vaccine Immune-Interception for Childhood Cancer Predisposition Syndromes |
Hospital for Sick Children / Uri Tabori, MD |
Crazy 8 Awards |
2025 |
Ontario |
Tracking Ewing Sarcoma Origin by Developmental and Trans-species Genomics |
St. Anna Children’s Cancer Research Institute / Heinrich Kovar, PhD |
Crazy 8 Awards |
2020 |
|
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia |
Boston Children’s Hospital / Alan Cantor, MD, PhD |
Innovation Grants |
2015 |
Massachusetts |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy |
Dana-Farber Cancer Institute / Yana Pikman, MD |
Young Investigator Grants |
2014 |
Massachusetts |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar, MD/PhD |
Reach Grants |
2024 |
Texas |